R3 Vascular Inc. | Company Profile - Revenue, Headcount, Tech Stack, Contacts

R3 Vascular Inc. is a medical device company based in Mountain View, California. The company specializes in developing advanced bioresorbable vascular scaffold (BVS) technology aimed at treating peripheral arterial disease (PAD). Their core product, the MAGNITUDE® drug-eluting bioresorbable scaffold, is designed to compete with traditional metal drug-eluting stents, particularly for below-the-knee arterial blockages. The MAGNITUDE scaffold features a unique polymer and manufacturing process that ensures a balance of strength and flexibility, with an ultra-thin strut thickness of 98 microns.

The company is currently conducting pivotal clinical trials, including the ELITE-BTK trial, focusing on patients with severe below-the-knee vessel blockages. This trial seeks to demonstrate the safety and efficacy of the MAGNITUDE scaffold, especially for patients at risk of limb amputation. Led by President and CEO Christopher Owens, an expert in medical device innovation, and founder Kamal Ramzipoor, Chief Technology Officer, their technology aims to enhance clinical outcomes for patients suffering from chronic limb-threatening ischemia and other forms of PAD.